You are here: Industry Insights > tumour

News List

Movember: reducing the adverse effects of testicular cancer treatments pharmaceutical
November 19, 2018
One of the three male-specific health causes focused upon during Movember is testicular cancer. Despite having a 95% survival rate。
Tumour immune cells could aid cancer therapies worldpharmanew
November 10, 2018
A pioneering technique designed to spot differences between immune cells in tumours could speed the development of cancer treatments, research suggests. Scientists say the approach could be used to help doctors choose the best treatments for individual pa
Tumour immune cells could aid cancer therapies worldpharmanew
November 10, 2018
A pioneering technique designed to spot differences between immune cells in tumours could speed the development of cancer treatments, research suggests. Scientists say the approach could be used to help doctors choose the best treatments for individual pa
Fluorescent marker to help guide surgeons remove brain tumours europeanpharmaceuticalreview
November 06, 2018
Researchers have used a fluorescent marker to aid surgeons in locating high-grade brain tumour cells, enabling accurate and safe removal…
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. pharmafile
October 31, 2018
Despite being the 7th most common cancer in the United Kingdom, 45% of patients were initially treated for less serious conditions such as urine infections, kidney stones or respiratory problems....
Mirati Therapeutics Announces Submission of IND for MRTX849 americanpharmaceuticalreview
October 31, 2018
Mirati Therapeutics has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2 trial with the initial goal to evaluate safety...
Researchers develop AI technique to treat cancer biospectrumasia
August 14, 2018
The new "self-learning" machine-learning technique could make the dosing regimen less toxic but still effective
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells europeanpharmaceuticalreview
May 03, 2018
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking…
Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumour tissue europeanpharmaceuticalreview
April 24, 2018
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens…
Ivermectin found to suppresses tumour development europeanpharmaceuticalreview
September 29, 2017
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer…

Previous page 1 2 3 4 5 Next page